Evidence map›Paper›PMID 41768258›Full record

ArticleFrontiers in oncology2026

Adult-type diffuse glioma prediction using MnasNet optimized by the advanced single candidate optimizer.

Beichuan Zhao

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Beichuan ZhaoThe First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse glioma is the most common and aggressive type of the primary brain tumor of adults that has few treatment options with poor prognosis. Existing diagnostic methods including biopsy and histopathological examination are invasive, time consuming and prone to inter-observer variations. To overcome these shortcomings, this paper suggests a non-invasive, deep learning-based approach to the prediction of adult-type diffuse glioma using preoperative T2-weighted MRI. The paradigm incorporates the alternated MnasNet design which is optimized by a new metaheuristic-based algorithm called the Advanced Single Candidate Optimizer (ASCO) but with the addition of opposition-based learning and Chebyshev chaotic map. The method was trained and tested on a pooled set of 533 patients, 237 of Nagoya University Hospital and 296 of a publicly accessible database coordinated of ground-truth (IDH mutation and 1p/19q codeletion status). Strict 10-fold cross-validation was conducted on an independent test set with a sensitivity of 95.11, specificity of 96.57, precision of 98.75, accuracy of 97.30, F1-score of 97.76 and a Matthews Correlation Coefficient of 92.62. Comparative analyses shows the best result toward six state of the art techniques to prove the clinical potential of the proposed system to predict glioma accurately and non-invasively.

Indexed as

adult-type diffuse gliomabrain tumor predictioncomputer-assisted diagnosisdeep learningimaging characteristicsmedical imaging analysisMnasNet

Identifiers

PMID41768258
PMCPMC12945832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.